The cerebral metabolic rate of oxygen consumption (CMRO2) is an important metric of brain metabolism. It is of particular interest in preclinical studies of Alzheimer’s disease, where amyloidosis has been associated with impaired mitochondrial function. CMRO2 can be measured by direct 17O-MRI of H217O signal changes during inhalation of 17O-labeled oxygen gas. In this study, we used 3D zero echo time 17O-(ZTE-)MRI at 11.7T to measure CMRO2 in the APP/PS1dE9 mouse model of amyloidosis and show that it is significantly lower than in control mice.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords